Swayze Eric's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jan 20, 2026
- Accession no.
- 0000874015-26-000072
- Filed
- Jan 20, 2026
- Trade date
- Jan 15-16, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 5 derivative transactions. Open-market sales total $748.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Swayze EricCIK 0001791058 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +21,366 | $0.00 | $0 | 51,819 | Direct | |
| Jan 16, 2026 | Common Stock | SSaleDisposed | −9,884 | $75.34 | −$744,660.56 | 41,935 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +111 | $0.00 | $0 | 367 | Indirect | |
| Jan 16, 2026 | Common Stock | SSaleDisposed | −49 | $75.97 | −$3,722.53 | 318 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | AGrant or awardAcquired | +25,800 | $0.00 | $0 | 90,282 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −21,366 | $0.00 | $0 | 39,251 | Direct | |
| Jan 15, 2026 | Common Stock | AGrant or awardAcquired | +9,675 | $0.00 | $0 | 48,926 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −111 | $0.00 | $0 | 386 | Indirect | |
| Jan 15, 2026 | Common Stock | AGrant or awardAcquired | +225 | $0.00 | $0 | 611 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.